249 related articles for article (PubMed ID: 8576489)
21. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation.
Fobben ES; Rubin CZ; Kalisher L; Dembner AG; Seltzer MH; Santoro EJ
Radiology; 1995 Jul; 196(1):143-52. PubMed ID: 7784558
[TBL] [Abstract][Full Text] [Related]
22. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
Uematsu T; Yuen S; Kasami M; Uchida Y
Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
[TBL] [Abstract][Full Text] [Related]
23. Breast microcalcifications studied with 3D contrast-enhanced high-field magnetic resonance imaging: more accuracy in the diagnosis of breast cancer.
Trecate G; Tess JD; Vergnaghi D; Bergonzi S; De Simone T; Mariani G; Musumeci R
Tumori; 2002; 88(3):224-33. PubMed ID: 12195761
[TBL] [Abstract][Full Text] [Related]
24. Dynamic MR mammography: a technique for potentially reducing the biopsy rate for benign breast disease.
Turkat TJ; Klein BD; Polan RL; Richman RH
J Magn Reson Imaging; 1994; 4(4):563-8. PubMed ID: 7949682
[TBL] [Abstract][Full Text] [Related]
25. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
[TBL] [Abstract][Full Text] [Related]
26. Critical pathways in analyzing breast calcifications.
Bird RE
Radiographics; 1995 Jul; 15(4):928-34. PubMed ID: 7569137
[TBL] [Abstract][Full Text] [Related]
27. Enhancing area surrounding breast carcinoma on MR mammography: comparison with pathological examination.
Van Goethem M; Schelfout K; Kersschot E; Colpaert C; Verslegers I; Biltjes I; Tjalma WA; Weyler J; De Schepper A
Eur Radiol; 2004 Aug; 14(8):1363-70. PubMed ID: 15045522
[TBL] [Abstract][Full Text] [Related]
28. New subtraction algorithms for evaluation of lesions on dynamic contrast-enhanced MR mammography.
Choi BG; Kim HH; Kim EN; Kim BS; Han JY; Yoo SS; Park SH
Eur Radiol; 2002 Dec; 12(12):3018-22. PubMed ID: 12439585
[TBL] [Abstract][Full Text] [Related]
29. [Subclinical breast lesions manifested by microcalcifications. Historadiologic correlations. Apropos of a retrospective series of 127 cases].
Avigdor S; Lebas P; du Rouchet E; Lansac J; Body G
J Gynecol Obstet Biol Reprod (Paris); 1994; 23(4):365-72. PubMed ID: 8051362
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of MRI of microcalcification lesions to determine the indication for stereotactic mammotome biopsy.
Kikuchi M; Tanino H; Kosaka Y; Sengoku N; Yamashita K; Minatani N; Nishimiya H; Waraya M; Katoh H; Enomoto T; Kajita S; Woodhams R; Watanabe M
Anticancer Res; 2014 Nov; 34(11):6749-53. PubMed ID: 25368286
[TBL] [Abstract][Full Text] [Related]
31. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
32. The value of dynamic contrast enhanced breast MRI in mammographically detected BI-RADS 5 microcalcifications.
Houserkova D; Prasad SN; Svach I; Kucerova L; Duskova M; Bucil J; Sisola I; Zlamalova N; Svebisova H
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):107-15. PubMed ID: 18795084
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance mammography in small vs. advanced breast lesions - systematic comparison reveals significant impact of lesion size on diagnostic accuracy in 936 histologically verified breast lesions.
Dietzel M; Baltzer PA; Vag T; Gröschel T; Richter C; Burmeister H; Kaiser WA
Rofo; 2011 Feb; 183(2):126-35. PubMed ID: 20830650
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast enhanced magnetic resonance imaging.
Kneeshaw PJ; Lowry M; Manton D; Hubbard A; Drew PJ; Turnbull LW
Breast; 2006 Feb; 15(1):29-38. PubMed ID: 16002292
[TBL] [Abstract][Full Text] [Related]
35. Breast lesion localization: a freehand, interactive MR imaging-guided technique.
Daniel BL; Birdwell RL; Ikeda DM; Jeffrey SS; Black JW; Block WF; Sawyer-Glover AM; Glover GH; Herfkens RJ
Radiology; 1998 May; 207(2):455-63. PubMed ID: 9577495
[TBL] [Abstract][Full Text] [Related]
36. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.
Viehweg P; Lampe D; Buchmann J; Heywang-Köbrunner SH
MAGMA; 2000 Dec; 11(3):129-37. PubMed ID: 11154954
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the role of dynamic contrast-enhanced MR imaging for patients with BI-RADS 3-4 microcalcifications.
Jiang Y; Lou J; Wang S; Zhao Y; Wang C; Wang D
PLoS One; 2014; 9(6):e99669. PubMed ID: 24927476
[TBL] [Abstract][Full Text] [Related]
38. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.
Strigel RM; Eby PR; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2010 Sep; 195(3):792-8. PubMed ID: 20729462
[TBL] [Abstract][Full Text] [Related]
39. Dynamic gradient-echo and fat-suppressed spin-echo contrast-enhanced MRI of the breast.
Kerslake RW; Carleton PJ; Fox JN; Imrie MJ; Cook AM; Read JR; Bowsley SJ; Buckley DL; Horsman A
Clin Radiol; 1995 Jul; 50(7):440-54. PubMed ID: 7614789
[TBL] [Abstract][Full Text] [Related]
40. Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast.
Van Goethem M; Schelfout K; Kersschot E; Colpaert C; Weyler J; Verslegers I; Biltjes I; De Schepper A; Parizel PM
JBR-BTR; 2005; 88(5):225-32. PubMed ID: 16302331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]